Tong Ren Tang Technologies Co Ltd
HKEX:1666
Tong Ren Tang Technologies Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.67
6.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Tong Ren Tang Technologies Co Ltd hold over its rivals?
What risks and challenges
does Tong Ren Tang Technologies Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Tong Ren Tang Technologies Co Ltd.
Provide an overview of the primary business activities
of Tong Ren Tang Technologies Co Ltd.
What unique competitive advantages
does Tong Ren Tang Technologies Co Ltd hold over its rivals?
What risks and challenges
does Tong Ren Tang Technologies Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Tong Ren Tang Technologies Co Ltd.
Provide P/S
for Tong Ren Tang Technologies Co Ltd.
Provide P/E
for Tong Ren Tang Technologies Co Ltd.
Provide P/OCF
for Tong Ren Tang Technologies Co Ltd.
Provide P/FCFE
for Tong Ren Tang Technologies Co Ltd.
Provide P/B
for Tong Ren Tang Technologies Co Ltd.
Provide EV/S
for Tong Ren Tang Technologies Co Ltd.
Provide EV/GP
for Tong Ren Tang Technologies Co Ltd.
Provide EV/EBITDA
for Tong Ren Tang Technologies Co Ltd.
Provide EV/EBIT
for Tong Ren Tang Technologies Co Ltd.
Provide EV/OCF
for Tong Ren Tang Technologies Co Ltd.
Provide EV/FCFF
for Tong Ren Tang Technologies Co Ltd.
Provide EV/IC
for Tong Ren Tang Technologies Co Ltd.
Show me price targets
for Tong Ren Tang Technologies Co Ltd made by professional analysts.
What are the Revenue projections
for Tong Ren Tang Technologies Co Ltd?
How accurate were the past Revenue estimates
for Tong Ren Tang Technologies Co Ltd?
What are the Net Income projections
for Tong Ren Tang Technologies Co Ltd?
How accurate were the past Net Income estimates
for Tong Ren Tang Technologies Co Ltd?
What are the EPS projections
for Tong Ren Tang Technologies Co Ltd?
How accurate were the past EPS estimates
for Tong Ren Tang Technologies Co Ltd?
What are the EBIT projections
for Tong Ren Tang Technologies Co Ltd?
How accurate were the past EBIT estimates
for Tong Ren Tang Technologies Co Ltd?
Compare the revenue forecasts
for Tong Ren Tang Technologies Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Tong Ren Tang Technologies Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Tong Ren Tang Technologies Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Tong Ren Tang Technologies Co Ltd compared to its peers.
Compare the P/E ratios
of Tong Ren Tang Technologies Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Tong Ren Tang Technologies Co Ltd with its peers.
Analyze the financial leverage
of Tong Ren Tang Technologies Co Ltd compared to its main competitors.
Show all profitability ratios
for Tong Ren Tang Technologies Co Ltd.
Provide ROE
for Tong Ren Tang Technologies Co Ltd.
Provide ROA
for Tong Ren Tang Technologies Co Ltd.
Provide ROIC
for Tong Ren Tang Technologies Co Ltd.
Provide ROCE
for Tong Ren Tang Technologies Co Ltd.
Provide Gross Margin
for Tong Ren Tang Technologies Co Ltd.
Provide Operating Margin
for Tong Ren Tang Technologies Co Ltd.
Provide Net Margin
for Tong Ren Tang Technologies Co Ltd.
Provide FCF Margin
for Tong Ren Tang Technologies Co Ltd.
Show all solvency ratios
for Tong Ren Tang Technologies Co Ltd.
Provide D/E Ratio
for Tong Ren Tang Technologies Co Ltd.
Provide D/A Ratio
for Tong Ren Tang Technologies Co Ltd.
Provide Interest Coverage Ratio
for Tong Ren Tang Technologies Co Ltd.
Provide Altman Z-Score Ratio
for Tong Ren Tang Technologies Co Ltd.
Provide Quick Ratio
for Tong Ren Tang Technologies Co Ltd.
Provide Current Ratio
for Tong Ren Tang Technologies Co Ltd.
Provide Cash Ratio
for Tong Ren Tang Technologies Co Ltd.
What is the historical Revenue growth
over the last 5 years for Tong Ren Tang Technologies Co Ltd?
What is the historical Net Income growth
over the last 5 years for Tong Ren Tang Technologies Co Ltd?
What is the current Free Cash Flow
of Tong Ren Tang Technologies Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Tong Ren Tang Technologies Co Ltd.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
CN |
T
|
Tong Ren Tang Technologies Co Ltd
HKEX:1666
|
6.2B HKD | 2.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
699.5B USD | 42.5 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 17 702.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.8B USD | 16.1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 14.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.7B CHF | 12.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
167.6B GBP | 192.8 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.3B CHF | 14.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
206.3B USD | 9.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
162.4B USD | 650.8 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
119.8B EUR | 13.3 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
CN |
T
|
Tong Ren Tang Technologies Co Ltd
HKEX:1666
|
Average EV/EBIT:
1 697.3
2.8
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
42.5
|
33%
|
1.3 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
17 702.3
|
98%
|
180.6 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
16.1
|
12%
|
1.3 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
14.3
|
16%
|
0.9 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
12.1
|
9%
|
1.3 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
192.8
|
21%
|
9.2 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
14.1
|
8%
|
1.8 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
9.7
|
12%
|
0.8 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
650.8
|
N/A | N/A |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
13.3
|
14%
|
0.9 |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.